Tag: Drug Approvals
FDA Approves New Antiplatelet Drug for Patients Undergoing PCI
Kengreal prevents blood platelets from accumulating during percutaneous coronary intervention
FDA: Improved Artificial Heart Valve Approved
Changes designed to minimize leaks
FDA: Brain Stimulation Device Approved for Parkinson’s
For use in Parkinson's disease and essential tremor after medication alone proves inadequate
FDA Approves Rapamune for Lymphangioleiomyomatosis
Rare, progressive lung disease affects mostly women of child-bearing age
FDA: Two Drugs Approved for Irritable Bowel Syndrome
U.S. Food and Drug Administration approves Viberzi (eluxadoline) and Xifaxan (rifaximin)
FDA Approves Avelox for Treatment of Plague
Yersinia pestis bacterium could be released intentionally in bioterrorism
FDA: Senza Device Relieves Spinal Pain Without Paresthesia
Implanted device treats chronic back pain
FDA Approves Raplixa to Help Control Surgical Bleeding
Spray-dried fibrin sealant promotes clotting when other methods are 'ineffective or impractical'
FDA Approves Kybella for Reducing Submental Fat
Use for fat outside submental area not approved, not recommended
FDA Approves First Generic Abilify
For treatment of bipolar disorder or schizophrenia
